“Detecting Demyelination by PET: The Lesion as Imaging Target.”
Brugarolas, P., D. S. Reich and B. PopkoMol Imaging, 2018.
Mol Imaging, 2018.
“Development of a PET radioligand for potassium channels to image CNS demyelination.”
Brugarolas, P., J. E. Sanchez-Rodriguez, H. M. Tsai, F. Basuli, S. H. Cheng, X. Zhang, A. V. Caprariello, J. J. Lacroix, R. Freifelder, D. Murali, O. DeJesus, R. H. Miller, R. E. Swenson, C. T. Chen, P. Herscovitch, D. S. Reich, F. Bezanilla and B. PopkoSci Rep, 2018.
“Defective cholesterol clearance limits remyelination in the aged central nervous system.”
Cantuti-Castelvetri, L., D. Fitzner, M. Bosch-Queralt, M. T. Weil, M. Su, P. Sen, T. Ruhwedel, M. Mitkovski, G. Trendelenburg, D. Lutjohann, W. Mobius and M. SimonsScience, 2018.
“Cholesterol crystals impede nerve repair.”
Chen, Y. and B. PopkoScience, 2018.
“Phosphorylation State of ZFP24 Controls Oligodendrocyte Differentiation.”
Elbaz, B., J. D. Aaker, S. Isaac, A. Kolarzyk, P. Brugarolas, A. Eden and B. PopkoCell Rep, 2018.
“Myelin remodeling through experience-dependent oligodendrogenesis in the adult somatosensory cortex.”
Hughes, E. G., J. L. Orthmann-Murphy, A. J. Langseth and D. E. BerglesNat Neurosci, 2018.
“Oligodendrocytes control potassium accumulation in white matter and seizure susceptibility.”
Larson, V. A., Y. Mironova, K. G. Vanderpool, A. Waisman, J. E. Rash, A. Agarwal and D. E. BerglesElife, 2018.
“A Subpopulation of Foxj1-Expressing, Nonmyelinating Schwann Cells of the Peripheral Nervous System Contribute to Schwann Cell Remyelination in the Central Nervous System.”
Ma, D., B. Wang, M. Zawadzka, G. Gonzalez, Z. Wu, B. Yu, E. L. Rawlins, R. J. M. Franklin and C. ZhaoJ Neurosci, 2018.
“Initiation of CNS Myelination in the Optic Nerve Is Dependent on Axon Caliber.”
Mayoral, S. R., A. Etxeberria, Y. A. Shen and J. R. ChanCell Rep, 2018.
“Oligodendrocyte-encoded Kir4.1 function is required for axonal integrity.”
Schirmer, L., W. Mobius, C. Zhao, A. Cruz-Herranz, L. Ben Haim, C. Cordano, L. R. Shiow, K. W. Kelley, B. Sadowski, G. Timmons, A. K. Probstel, J. N. Wright, J. H. Sin, M. Devereux, D. E. Morrison, S. M. Chang, K. Sabeur, A. J. Green, K. A. Nave, R. J. Franklin and D. H. RowitchElife, 2018.
“The ubiquitin-proteasome system: A potential therapeutic target for heart failure.”
Barac, Y. D., F. Emrich, E. Krutzwakd-Josefson, S. Schrepfer, L. C. Sampaio, J. T. Willerson, R. C. Robbins, A. Ciechanover, F. W. Mohr, D. Aravot and D. A. TaylorJ Heart Lung Transplant, 2017.
“Targeting tryptophan catabolic kynurenine pathway enhances antitumor immunity and cytotoxicity in multiple myeloma.”
Ray, A., Y. Song, T. Du, Y. T. Tai, D. Chauhan and K. C. AndersonLeukemia, 2020.
“Activating KRAS, NRAS, and BRAF mutants enhance proteasome capacity and reduce endoplasmic reticulum stress in multiple myeloma.”
Shirazi, F., R. J. Jones, R. K. Singh, J. Zou, I. Kuiatse, Z. Berkova, H. Wang, H. C. Lee, S. Hong, L. Dick, N. Chattopadhyay and R. Z. OrlowskiProc Natl Acad Sci U S A, 2020.
“A novel BCMA PBD-ADC with ATM/ATR/WEE1 inhibitors or bortezomib induce synergistic lethality in multiple myeloma.”
Xing, L., L. Lin, T. Yu, Y. Li, S. F. Cho, J. Liu, K. Wen, P. A. Hsieh, K. Kinneer, N. Munshi, K. C. Anderson and Y. T. TaiLeukemia, 2020.
“Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma.”
Zavidij, O., N. J. Haradhvala, T. H. Mouhieddine, R. Sklavenitis-Pistofidis, S. Cai, M. Reidy, M. Rahmat, A. Flaifel, B. Ferland, N. K. Su, M. P. Agius, J. Park, S. Manier, M. Bustoros, D. Huynh, M. Capelletti, B. Berrios, C. J. Liu, M. X. He, E. Braggio, R. Fonseca, Y. Maruvka, J. L. Guerriero, M. Goldman, E. van Allen, S. A. McCarroll, J. Azzi, G. Getz and I. M. GhobrialNat Cancer, 2020.
“The novel protein homeostatic modulator BTX306 is active in myeloma and overcomes bortezomib and lenalidomide resistance.”
Zou, J., R. J. Jones, H. Wang, I. Kuiatse, F. Shirazi, E. E. Manasanch, H. C. Lee, R. Sullivan, L. Fung, N. Richard, P. Erdman, E. Torres, D. Hecht, I. Lam, B. McElwee, A. H. Chourasia, K. W. H. Chan, F. Mercurio, D. I. Stirling and R. Z. OrlowskiJ Mol Med (Berl), 2020.